Contact
Please use this form to send email to PR contact of this press release:
Trailblazing AI Driven Early Cancer Diagnostics & Therapeutics for Detection with Nvidia Super Computing: NASDAQ: RENB
TO:
The Hon. Mark Dybul, MD, CEO
Renovaro Biosciences Inc
+1 732-780-5036